Cannara Biotech Inc (LOVE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 6,685 | 6,353 | 4,942 | 3,921 | 3,026 |
| Income taxes - deferred | 5,021 | -1,955 | N/A | N/A | N/A |
| Accounts receivable | -223 | -2,057 | -1,217 | -5,183 | -2,549 |
| Accounts payable and accrued liabilities | 528 | 2,219 | N/A | N/A | N/A |
| Other Working Capital | -6,304 | -2,499 | -6,113 | -11,483 | -3,820 |
| Other Operating Activity | 14,308 | 8,621 | 7,825 | 6,667 | 1,250 |
| Operating Cash Flow | $20,013 | $10,683 | $5,437 | $-6,079 | $-2,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,200 | -7,452 | -9,690 | -15,404 | -30,856 |
| Other Investing Activity | 250 | 2,264 | 212 | 59 | 27 |
| Investing Cash Flow | $-5,950 | $-5,188 | $-9,478 | $-15,345 | $-30,829 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 499 | 3,259 | 3,000 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 0 | 10,700 |
| Debt Repayment | -3,081 | -2,225 | -2,243 | -34,300 | -668 |
| Common Stock Issued | N/A | N/A | N/A | 0 | 24,300 |
| Common Stock Repurchased | 0 | -277 | -374 | N/A | N/A |
| Other Financing Activity | -3,742 | -3,902 | -4,102 | 59,764 | -1,080 |
| Financing Cash Flow | $-6,324 | $-3,145 | $-3,719 | $25,464 | $33,252 |
| Exchange Rate Effect | N/A | 0 | -84 | -85 | 58 |
| Beginning Cash Position | 6,620 | 4,271 | 12,115 | 8,159 | 7,771 |
| End Cash Position | 14,360 | 6,620 | 4,271 | 12,115 | 8,159 |
| Net Cash Flow | $7,740 | $2,350 | $-7,760 | $4,040 | $330 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,013 | 10,683 | 5,437 | -6,079 | -2,093 |
| Capital Expenditure | -6,359 | -7,469 | -9,879 | -15,467 | -31,074 |
| Free Cash Flow | 13,655 | 3,214 | -4,443 | -21,546 | -33,167 |